DERIVATISATION OF PROTEINS IN AQUEOUS SOLUTION
    8.
    发明授权
    DERIVATISATION OF PROTEINS IN AQUEOUS SOLUTION 有权
    衍生化蛋白的水性溶剂

    公开(公告)号:EP1335931B1

    公开(公告)日:2005-12-21

    申请号:EP01931843.5

    申请日:2001-05-14

    摘要: Proteins are derivatised by reaction of pendant groups, usually groups which are side chains in non-terminal amino acyl units of the protein, in aqueous reactions in the presence of a denaturant. The denaturant is preferably an amphiphilic compound, most preferably an anionic amphiphilic compound such as a long chain alkyl sulphate mono ester, preferably an alkaline metal salt, for instance sodium dodecyl sulphate. The degree of derivatisation is increased, whilst the protein retains activity, such as enzyme activity. The increase in the degree of derivatisation enhances the increase in circulation time in vivo and stability on storage and in vivo. Preferably the derivatising reagent is an aldehyde compound which reacts with primary amine groups, generally the epsilon-amino group of lysyl units. Derivatisation is conducted under reducing conditions to generate a secondary amine derivative.

    "> Kallikrein-inhibiting
    9.
    发明公开
    Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same 失效
    激肽释放酶抑制“Kunitz结构域”的蛋白质的核酸编码

    公开(公告)号:EP1484339A3

    公开(公告)日:2005-03-02

    申请号:EP04019920.0

    申请日:1995-01-11

    申请人: Dyax Corporation

    摘要: This invention relates to nucleic acids encoding novel BPTI-homologous Kunitz domains, especially LACI homologues, which inhibit one or more plasma (and/or tissue) kallikreins, and to the therapeutic and diagnostic use of these novel proteins. In particular, the Kunitz domains are derived from Kunitz domains of human origin and especially to the first Kunitz domain of LACI. Additionally, the invention relates to recombinant expression vectors comprising a nucleic acid according to the invention, methods for producing a kallikrein binding domain, isolated polypeptides comprising a Kunitz domain structure, pharmaceutical compositions thereof as well as the use of the same and methods of assaying the presence of kallikrein or of purifying kallikrein.